Hailey-Hailey disease is an autosomal genetic disease caused by mutations in one of the two ATP2C1 alleles encoding the secretory pathway Ca2+/Mn2+-ATPase, hSPCA1. The disease almost exclusively affects epidermis, where it mainly results in acantholysis of the suprabasal layers. The etiology of the disease is complex and not well understood. We applied a yeast based complementation system to characterize fourteen disease-causing ATP2C1 missense mutations in presence or absence of wild type ATP2C1 or ATP2A2, encoding SERCA2. In our yeast model system, mutations in ATP2C1 affected Mn2+ transport more than Ca2+ transport as twelve out of fourteen mutations were unable to complement Mn2+ sensitivity while thirteen out of fourteen to some extent complemented the high Ca2+requirement. Nine out of fourteen mutations conferred a cold sensitive complementation capacity. In absence of a wild type ATP2C1 allele, twelve out of fourteen mutations induced an unfolded protein response indicating that in vivo folding of hSPCA1 is sensitive to disease causing amino acid substitutions and four of the fourteen mutations caused the hSPCA1 protein to accumulate in the vacuolar membrane. Co-expression of either wild type ATP2C1 or ATP2A2 prevented induction of the unfolded protein response and hSPCA1 mis-localization.
Hailey-Hailey disease (HHD), also known as familial benign chronic pemphigus, is a rare, dominantly inherited, autosomal skin-disorder, mainly characterized by loss of cohesion (acantholysis) between keratinocytes in the suprabasal layers of the skin. Mutations in the ATP2C1 gene, encoding the Secretory Pathway Ca2+/Mn2+-ATPase Type 1 (hSPCA1) are known to cause HHD1,2 but the underlying mechanism of the disease is far from fully understood. The various model systems that have been used to study the molecular cause of HHD have revealed a disease with great complexity3,4,5,6.
Despite that currently more than 180 mutations in ATP2C1 have been deposited in the Human Gene Mutation Database Professional (www.hgmd.cf.ac.uk/ac/index.php), and more than 170 have been listed in recent publications7,8 only few have been functionally characterized9. The amino acid substitutions causing HHD do not cluster in specific parts of the hSPCA1 primary structure.
hSPCA1 belongs to the family of P-type ATPases - a group of transmembrane proteins that uses the energy in ATP to transport one or more substances across the membrane, in a process involving transient phosphorylation of a conserved aspartate residue10.
Four different splice variants of the human hSPCA1, named hSPCA1a-d have been experimentally verified11. These hSPCA1 isoforms only differ in their carboxyl-termini. The shortest isoform, hSPCA1c has been shown to be nonfunctional, but the remaining hSPCA1a, -b and –d isoforms all have similar kinetic properties12. The precise functional differences among these three variants are still unclear but carboxyl termini of other P-type ATPases are known to play a regulatory role13,14,15.
hSPCA1 localizes to Golgi membranes, particularly trans-Golgi16, where it transports Ca2+ and Mn2+ ions into the Golgi lumen11,17. ATP2C1 is ubiquitously expressed in mammalian cells but expression is particularly high in epidermal keratinocytes and varies among other human tissues2,18,19. hSPCA1 accumulation has been shown to be markedly reduced in keratinocytes from HHD patients16. While ATP2C1 mutations are disease causing, the complete etiology of the disease is apparently more complex, as only parts of the skin are affected and most patients are symptom-free for the first 2–4 decades of life. It is currently not known how mutations in ATP2C1 lead to the clinical phenotype and why mainly skin is affected. It is generally believed that the reduced ability to pump Ca2+ into Golgi, resulting from haploinsufficiency, is the main cause of HHD20,21,22. The suggestion that a perturbed cellular Ca2+ homeostasis is at the root of HHD is further supported by the fact that a Ca2+ has several important roles in the skin2,16,23,24,25,26,27,28,29.
The Saccharomyces cerevisiae hSPCA1 orthologue Pmr1 was the first secretory pathway Ca2+-ATPase to be identified and characterized30,31,32. Consequently, most of the knowledge we have on SPCA comes from studies of yeast Pmr1. Like its human counterpart, Pmr1 localizes mainly to Golgi but it is also present in low amounts in the ER membrane17,31,32,33,34. Like hSPCA1, Pmr1 transports Ca2+ and Mn2+ ions across the ER/Golgi membrane33, and one of its functions is to supply ER and Golgi resident enzymes such as glycosyltransferases, kinases and proteases with Mn2+ or Ca2+7,30,31,33,35,36,37,38. The requirement for Ca2+ ions in ER/Golgi may explain why pmr1Δ yeast cells are sensitive to very low extracellular Ca2+ concentrations33,39,40. pmr1Δ yeast cells are also hypersensitive to elevated extracellular Mn2+ concentrations17,41,42 as they cannot clear Mn2+ ions from the cytoplasm, which is essential, as an elevated Mn2+ concentration in the cytoplasm is toxic43,44,45,46,47,48.
Human SPCA1 shows 49% homology with yeast Pmr1 and has previously been shown to fully complement the high Ca2+ requirement and the Mn2+ sensitivity of pmr1Δ yeast17. Yeast is a unique model organism for studying hSPCA1 mutations as it is currently the only background-free system that allows all endogenous intracellular Ca2+- and Mn2+ ATPases (PMR1 and PMC1) to be knocked out. Since yeast also lacks other secretory pathway Ca2+ pumps (i.e. SERCA-type Ca2+ ATPases) and Mn2+ pumps, potential interferences from these pumps are absent, too. Loss of both SPCA1 alleles in humans has only been described in very few cases49,50 and only as postzygotic, segmental loss of the healthy allele, with a more severe phenotype in the affected areas, indicating that SPCA1 is most likely essential. This is further corroborated by the fact that homozygous knock-out of SPCA1 or SERCA2 in mouse is lethal in the embryonal stage22,51. Taken together this indicates that a background-free mammalian model system may be unachievable.
Proper functionality of a protein is dependent on the specific three dimensional structure of the polypeptide chain. Interference with protein folding in the ER, e.g. due to amino acid substitutions, prevention of disulphide bond formation or inhibition of glycosylation52, induces an evolutionary conserved and thoroughly investigated signal transduction pathway designated the unfolded protein response (UPR)53. In mammalian cells UPR can be induced by three different pathways, mediated by three different sensor proteins: PERK, ATF6 and IRE1. The IRE1 pathway is highly conserved among eukaryotes and also exists in yeast53,54,55,56. Thus, proteins that induce UPR in yeast are expected to induce UPR in mammalian cells, too. Accumulation of misfolded and unfolded proteins in the ER can lead to ER stress and prolonged or chronic ER stress can ultimately cause apoptosis53,57.
In the present study, we have used Saccharomyces cerevisiae as model organism for heterologous expression of wild type (wt) and 14 missense variants of ATP2C1 identified in diagnosed HHD patients. We chose to investigate the shortest functional isoform, hSPCA1a, as this is the “canonical” isoform and because mutations affecting the function of the shortest form would most likely also affect the longer splice variants as only the C-termini differ among isoforms and no missense mutations affect this region7. We investigated how gene copy number affects the in-vivo Ca2+ and Mn2+ transport capacity of HHD mutants including its temperature dependency, intracellular localization and accumulation of hSPCA1a protein, in addition to ER-stress induced by expression of HHD variants. In addition we also investigated the effects of co-expressing wild type ATP2C1 or ATP2A2, encoding SERCA2.
Expression of ATP2C1a in Saccharomyces cerevisiae
To address to what extent ATP2C1a gene dosage, temperature, protein accumulation, protein localization and interference with in vivo hSPCA1a protein folding may contribute to the etiology of HHD we selected fourteen disease-causing amino acid substitutions located in various domains of the hSPCA1a primary structure (Fig. 1) and expressed them in the pmc1Δ pmr1Δ cnb1Δ yeast strain PAP4920 or derivatives. As Hailey-Hailey patients usually carry one wt allele and one mutant allele, as well as other Ca2+-ATPases we additionally generated yeast strains that co-express either wt ATP2C1a (encoding hSPCA1a) or wt ATP2A2b (encoding hSERCA2b) and each of the investigated mutant alleles. The PAP4920 strain was selected because it is presently the only eukaryotic cell model without endogenous Ca2+ and Mn2+-ATPase activity and it is equipped with a chromosomally integrated unfolded protein response reporter58 for monitoring in vivo protein folding problems in the ER due to hSPCA1a expression.
Most HHD-associated ATP2C1a variants affect in vivo Ca2+ transport in a copy number dependent way
Increasing the CaCl2 concentration in the growth media from the standard 0.4 µM59 to 20 mM60 results in a concentration high enough to supply intracellular organelles with sufficient Ca2+ in the pmc1Δ pmr1Δ cnb1Δ yeast strain61. Requirement for a high extracellular Ca2+ concentration can be complemented by human wt ATP2C1a17. To obtain detailed information on how complementation depends on ATP2C1a gene dosage, yeast cells producing wt hSPCA1a or HHD variants from either a single cDNA copy (integrative) or approximately twenty copies (replicative, Supplementary Fig. S1) were grown in 96-well microplates at 30 °C in twelve different media, each having a unique Ca2+ concentration (Figs 2 and 3). The growth profiles obtained from this microplate assay reflect how efficient each hSPCA1a variant is at distributing cytosolic Ca2+ into the secretory pathway.
Data in Figs 2 and 3 show that yeast cells carrying either the chromosomally integrated or the replicative empty expression vector sustained growth at BAPTA concentrations up to 0.04 mM, while growth of yeast cells expressing wt ATP2C1a from either a single cDNA copy or from twenty copies was hardly affected by the applied BAPTA concentrations. Irrespective of copy number amino acid substitutions L318P, C344Y and I580V showed a BAPTA dependent growth profile similar to wt. In contrast 10 out of 14 mutants showed a copy number dependent complementation capacity as A304T, G309C, C411R, C490F, T570I, L584P, M641R, G645R, T709M and D742Y sustained growth no better or only marginally better than the empty vector when expressed from the integrative plasmid, but at a copy number of twenty A304T, C490F and L584P showed BAPTA dependent growth profiles similar to wt. The complementation capacity of the other seven variants (G309C, C411R, T570I, M641R, G645R, T709M and D742Y) was significantly better than the empty vector but poorer than wt. HHD variant G789R stands out as it did not confer any BAPTA tolerance greater than that of the empty vector when expressed from a single cDNA copy and was only marginally better than empty vector when expressed from the multi copy plasmid. The BAPTA related phenotypes of all HHD variant are summarized in Table 1.
Most HHD mutations show copy number independent Mn2+ sensitivity
Growth of pmc1Δ pmr1Δ cnb1Δ yeast is very sensitive to Mn2+ as absence of Pmr1 abolishes removal of toxic amounts of Mn2+ accumulating in the cytosol17. To obtain detailed information on how ATP2C1a gene dosage influences complementation of the Mn2+ sensitive phenotype, yeast cells producing wt hSPCA1a or HHD variants from either a single cDNA copy or approximately twenty copies were grown in 96-well microplates at 30 °C in 12 different growth media (Figs 4 and 5). Mn2+ concentrations between 1.0 mM and 2.0 mM MnSO4 were investigated because yeast expressing wt hSPCA1a showed differential growth in this interval and 1.0 mM MnSO4 was sufficient to prevent growth of cells carrying the empty vector.
Although growth of yeast cells expressing wt ATP2C1a from both a single cDNA copy and approximately twenty copies was sensitive to Mn2+, growth was sustained up till 2.0 mM Mn2+ (Figs 4 and 5). Of the fourteen investigated HHD variants only I580V conferred a copy number independent Mn2+ resistance on par with wt, while C344Y showed some Mn2+ resistance and only when expressed from the replicative plasmid. The remaining 12 variants were all unable to rescue the Mn2+ sensitive phenotype at any copy number. The Mn2+ sensitivity is summarized in Table 1.
Amino acid substitutions in HHD preferentially interfere with in vivo Mn2+ transport
As summarized in Table 1 a majority of the investigated HHD variants (A304T, G309C, C411R, C490F, M641R, G645R, D742Y and G789R) neither complemented the Mn2+ toxicity nor the BAPTA sensitivity better than the empty vector when expressed from a single cDNA copy (Figs 2 and 4). HHD variants T570I, L584P and T709M showed Ca2+ transport only marginally better than the empty vector but no Mn2+ transport when expressed from a single cDNA copy. HHD variants L318P, C344Y and I580V stood out, as the two former showed wt like Ca2+ transport capacity but were devoid of any Mn2+ transport capacity, while I580V complemented BAPTA sensitive growth and Mn2+ toxicity equally well as wt.
When expressed from the replicative vector, all HHD variants except G789R were to some extent able to complement the BAPTA-sensitive growth phenotype of the pmc1Δ pmr1Δ cnb1Δ strain (Fig. 3), whereas only C344Y and I580V were able to sustain growth on Mn2+ media (Fig. 5). HHD variants L318P, C344Y, C490F, I580V and L584P showed a wt-, or near wt-like phenotype in presence of BAPTA. Three of the five mutations showed no Mn2+ transport, only I580V showed a wt-like Mn2+ resistant growth phenotype and C344Y showed partial Mn2+ resistance. Substitutions T570I, T709M and D742Y also showed considerably BAPTA resistance but no Mn2+ resistance while G789R showed no Ca2+ transport and no Mn2+ transport. I580V was the only one to show a copy number independent wt phenotype with respect to both Ca2+ and Mn2+ transport.
Compared to wt and single pmr1 knockout strains a pmc1Δ pmr1Δ yeast strain shows substantially increased influx of Ca2+ and elevated Ca2+ accumulation when grown in low Ca2+ media6. Increased cytosolic Ca2+ activates the serine/threonine phosphatase calcineurin6,62 causing dephosphorylation and potential subsequent inhibition of Cch1, a subunit of the channel that forms the high affinity Ca2+-uptake system (HACS)61,62,63. Since our yeast model system lacks PMR1, PMC1 and CNB1, Ca2+ may hyper-accumulate in the cytoplasm and generate a large concentration gradient across the membranes of ER/Golgi. Thus, even a poorly functioning Ca2+-ATPase may appear to have a significant Ca2+-transport activity. This could severely influence the observed difference in Ca2+ and Mn2+ transport of the investigated HHD variants (Figs 2–5). As most of the investigated HHD-hSPCA1a variants displayed some degree of Ca2+ transporting activity, we tested the BAPTA and Mn2+ tolerance of the investigated hSPCA1a variants expressed from the replicative plasmid in a pmr1Δ single knockout strain. The results in Supplementary Figs S2 and S3 show that the BAPTA and Mn2+ tolerance conferred by the hSPCA1a variants in the pmr1Δ strain is similar to that observed in the triple pmr1Δ pmc1Δ cnb1Δ strain. This suggests that the observed BAPTA and Mn2+ tolerance of the tested HHD-SPCA1a variants reflects ATPase function and is not caused by hyper-accumulation of Ca2+ in the cytoplasm.
HHD-mutations do not exert a dominant-negative effect on wt hSPCA1a
HHD patients are heterozygous for the ATP2C1 gene. To investigate the effects of co-expressing each HHD variant with wt hSPCA1 we analyzed the complementation capacity using the micro plate growth assay. As our results with homozygous hSPCA1a expression showed gene dosage dependent complementation (Figs 2–5), we co-expressed wt ATP2C1a and each of the HHD-ATP2C1a variants from a single cDNA copy (heterozygous, integrative, Supplementary Figs S4 and S5) and wt ATP2C1a and each of the HHD- ATP2C1a variants from multi copy plasmids (heterozygous, replicative, Supplementary Figs S6 and S7).
Several HHD-variants display sensitivity to Ca2+
For each HHD allele we expected a positive correlation between Ca2+ availability in the medium and complementation as we are well below the level where Ca2+ becomes toxic40. However, many of the investigated HHD-variants display a more complex growth phenotype. In addition to the BAPTA sensitive growth described in a previous paragraph, data in Fig. 6 show that some of the mutants exposed a Ca2+-sensitive phenotype. This was observed in liquid media containing galactose and 20 mM CaCl2 (Figs 2 and 3), on agar plates containing galactose and 20 mM CaCl2 or agar plates containing galactose and 0 mM BAPTA (and no added Ca2+) (Fig. 6). The same HHD variants that showed a Ca2+-sensitive growth inhibition were at least able to grow on media containing the lowest amount of BAPTA.
To simplify, the growth phenotypes observed on agar plates containing Ca2+ or BAPTA at 30 °C from Fig. 6 are summarized in Supplementary Fig. S8. When expressed from the integrative vector at 30 °C on agar plates only L318P exposed a Ca2+-sensitive growth phenotype on media containing galactose and 0 mM BAPTA.When expressed from the replicative vector at 30 °C on agar plates, 10 of the 14 investigated HHD-mutants, including G309C, L318P, C411R, C490F, T570I, L584P, M641R, G645R, T709M and D742Y, displayed Ca2+-sensitivity in media containing galactose and 20 mM CaCl2 or galactose and 0 mM BAPTA. The observed growth inhibition is not simply caused by the presence of an excess amount of Ca2+ in the growth medium since all variants, including the empty vector (EV), sustained growth on agar plates containing glucose and 20 mM CaCl2 at 30 °C. The inhibition is also not caused by the combination of galactose and 20 mM CaCl2 since the negative control (empty vector, EV) could sustain growth at media containing galactose and 20 mM CaCl2. The inhibition is thus caused by expression of particular ATP2C1a alleles (i.e. the phenotype is restricted to growth on galactose) and the level of expression of the HHD-alleles (as the growth inhibition was much more pronounced for the replicative variants) in combination with the particular concentration of Ca2+ in the medium.
A similar inhibition of growth at 0 mM BAPTA was also observed in liquid media (Figs 2 and 3). While inhibition of growth on agar plates containing no added Ca2+ and no BAPTA was observed for the majority of the investigated HHD-alleles only HHD-variants L318P and C344Y showed growth inhibition at 0 mM BAPTA when expressed from the integrative vector (Fig. 2, the red curve with triangle symbols is below all other growth curves). Similarly, when expressed from the replicative plasmid, far fewer HHD-variants showed growth inhibition in liquid media, compared to solid media (Fig. 3). HHD-variants A304T, L318P, C490F, L584P and T709M showed a clear inhibition when grown at 0 mM BAPTA. Only three of the 8 HHD-mutants that showed growth inhibition in galactose and 20 mM CaCl2 on solid media displayed growth inhibition in galactose and 20 mM CaCl2 in liquid media. There is thus no clear correlation between growth inhibition in liquid media and in solid media.
Cold sensitivity is a common phenotype exposed by HHD-mutants
The growth experiments in Figs 2 and 3 revealed that most HHD-hSPCA1a variants retained some Ca2+ transport activity at 30 °C depending on plasmid copy number while Mn2+ transport was more affected. To investigate whether temperature effects the ability of the HHD-hSPCA1a variants to complement the BAPTA sensitive and Mn2+ sensitive growth phenotypes of the pmc1Δ pmr1Δ cnb1Δ host strain, yeast expressing wt ATP2C1a, HHD-ATP2C1a or no ATP2C1a from either the integrative plasmid or the replicative plasmid (Supplementary Fig. S1), were spotted on agar plates and incubated at 15 °C, 20 °C, 25 °C, 30 °C or 35 °C (Fig. 6).
Apart from yeast carrying the empty expression vector, only amino acid substitution G789R abolished functionality at any temperature and BAPTA concentration. The remaining 13 HHD mutants were able to grow to some extent and depending on copy number, at BAPTA concentrations not tolerated by the empty vector-control strain. The complementation capacity for each HHD-ATP2C1a variant with respect to temperature is summarized in Fig. 7.
It can be seen from Fig. 7 that relative to wt and irrespective of copy number, HHD-variants L318P, C344Y, L584P, T709M and D742Y conferred a very clear cold sensitive (CS) phenotype, displaying poorer or no BAPTA tolerance at lower temperatures. However, it can be seen from Fig. 6 that complementation by most CS-mutants was observed at a wider range of temperatures when ATP2C1a was expressed from the multi copy plasmid compared to expression from the single copy, integrative plasmid. HHD-variants A304T, C411R, M641R and G645R also displayed a CS phenotype, albeit less clear than the HHD-mutations mentioned above. Only substitutions C490F and I580V conferred a heat sensitive phenotype, the former only when expressed from the multi copy plasmid and the latter most pronounced when expressed from the multi copy plasmid. Amino acid substitutions G309C and T570V each showed a more complex phenotype. G309C only complemented weakly at 30 °C and 35 °C at a copy number of twenty and one respectively, indicating a CS-like phenotype; T570I only showed complementation at 20 °C and 25 °C and only after expression from the single copy plasmid, indicating a mixed temperature sensitive phenotype.
Interestingly, the observed Ca2+ sensitive phenotype did not display temperature variations among the various HHD-variants, but instead displayed a generally less pronounced Ca2+ sensitivity at 15 °C.
The degree of complementation on solid medium is complicated to quantify in contrast to growth in liquid media. To confirm the combined effects of temperature and ATP2C1a copy number observed in the spot assays in Fig. 6, we investigated BAPTA sensitive growth at 35 °C (Supplementary Figs S9 and S10) in liquid media in microplates for comparison with growth at 30 °C (Figs 2 and 3). For this analysis we selected representative mutants showing different phenotypes at 30 °C and 35 °C on agar plates (L318P, C344Y, I580V, L584P, M641R, T709M and G789R). In agreement with the temperature profiles in Fig. 7, the microplate results in Fig. 2 and Supplementary Fig. S9 show that after single copy expression wt performs better at 30 °C than at 35 °C and L318P complements equally well at both temperatures and better than wt at 35 °C. C344Y is seen to complement equally well at 30 °C and 35 °C, while I580V is performing considerably better at 30 °C than at 35 °C. In accordance with the plate assay L584P, M641R and T709M each complemented better at 35 °C than at 30 °C in liquid medium. G789R was included as a control as it does not perform better than the empty vector at any of the investigated temperatures. The microplate results in Fig. 3 and Supplementary Fig. S10 from multi-copy expression confirm the spot assays as wt is seen to perform better at 30 °C than at 35 °C, L584P performs better at 30 °C than at 35 °C, while C344Y performs well independent of temperature. The ability of L318P and I580V to complement is considerable reduced at 35 °C compared to 30 °C, while complementation by M641R is marginally reduced at 35 °C. T709M performs better at 35 °C than at 30 °C while G789R was included as a control as it does not complement at any temperature. In agreement with the data in Fig. 6 it can be seen from Figs 2 and 3 that integrative expression of L318P and I580V caused better complementation than the corresponding replicative expression.
HHD-hSPCA1a protein accumulation is allele specific
In order to investigate how the combination of HHD mutation and temperature affects hSPCA1a protein accumulation, we C-terminally tagged wt- and the 14 different HHD hSPCA1a variants, as well as the yeast endogenous Ca2+ ATPases Pmc1 and Pmr1, with yeast enhanced GFP (yEGFP), and expressed them from the replicative vector at 15 °C, 20 °C, 25 °C, 30 °C and 35 °C in the pmc1Δ pmr1Δ cnb1Δ strain PAP4920. Data in Supplementary Fig. S11 show that presence of the GFP tag does not influence the activity of hSPCA1a. GFP fluorescence emitted from equal amounts of purified yeast membranes therefore reflects membrane accumulation of GFP tagged hSPCA1a protein. Figure 8 shows that Pmc1 and Pmr1 accumulated in a more or less temperature-insensitive way. Wild type hSPCA1a accumulated to a comparable level as the endogenous Ca2+ ATPases at 30 °C and 35 °C while at 15 °C, 20 °C and 25 °C, it accumulated to 2–3 times the density observed for Pmc1 and Pmr1. HHD-variants A304T, G309C, L318P, I580V, G645R, T709M and D742Y protein accumulation was comparable to that of the wt hSPCA1a. Of these, G309C, G645R and T709M accumulated hSPCA1a protein in a more or less temperature insensitive manner. A304T and L318P protein accumulation peaked at 25 °C while both I580V and D742Y peaked at 30 °C. The remaining 7 HHD-variants all accumulated protein well below that observed for wt but on par with the Pmr1 orthologue. From the data summarized in Table 1 we conclude that temperature does not have a great effect on protein accumulation in the majority of the investigated HHD-mutations, but the different HHD variants accumulate to different densities in yeast membranes.
Intracellular localization of HHD-hSPCA1a variants is affected by calcium homeostasis
It may be anticipated that localization of hSPCA1a to the same intracellular compartment as the endogenous Pmr1 protein is a requirement for functional complementation of the calcium and manganese related phenotypes exposed by the pmc1Δ pmr1Δ cnb1Δ strain. To determine sub-cellular localization of wt and HHD hSPCA1a variants we expressed GFP tagged hSPCA1a variants and the endogenous Pmr1 and Pmc1 at 15 °C, 20 °C, 25 °C, 30 °C and 35 °C in the pmc1Δ pmr1Δ cnb1Δ strain. Live cell bioimaging of yeast cells producing GFP tagged Pmr1 or Pmc1 (Fig. 9) revealed localization to small punctuate structures scattered in the cytosol and the vacuolar membrane, respectively. The former is a characteristic appearance for yeast Golgi17,31. The live cell bioimaging data in Fig. 9 show that all HHD-hSPCA1a-GFP fusions except G309C, I580V, G645R and D742Y localized similarly to wt hSPCA1a-GFP and Pmr1-GFP. G309C, I580V, G645R and D742Y primarily revealed a Pmc1-like distribution, i.e. typical vacuolar membrane localization. To uniquely identify the vacuolar membrane we stained yeast cells expressing each of these variants with the specific vacuolar membrane stain FM4-64 (Fig. 10). Activity of the hSPCA1a protein does not seem to cause mislocalization as I580V shows wt-like activity, G309C only have minor Ca2+-transport activity and no Mn2+-transport activity and G645R and D742Y are devoid of activity. To be sure to have a completely inactive mutant we included hSPCA1a variant D350N that is completely devoid of any transport capacity44,64,65. As can be seen from Fig. 10, D350N accumulated in the vacuolar membrane as did the endogenous Pmc1.
To clarify whether mislocalization of the four HHD variants in some way reflects altered calcium homeostasis and/or manganese homeostasis we expressed wt hSPCA1a and all HHD variants in the wt yeast strain PAP150065. This yeast strain carries intact PMR1, PMC1 and CNB1 genes and therefore is anticipated to have a normal Ca2+ and Mn2+ homeostasis, independent of the performance of the expressed hSPCA1a (Fig. 11). As can be seen from Fig. 11, all GFP tagged hSPCA1a variants localized correctly to the Golgi compartment, as did the GFP tagged Pmr1. As expected, the GFP tagged Pmc1 localized to the vacuolar membrane. This indicates that an altered Ca2+ and/or Mn2+ homeostasis may cause the observed vacuolar mislocalization of some of the HHD-hSPCA1a variants.
To further clarify whether mislocalization of HHD variants G309C, I580V, G645R and D742Y as well as the functionally inactive D350N reflects altered Ca2+ homeostasis and/or Mn2+ homeostasis we co-expressed BFP tagged wt hSPCA1a and GFP tagged versions of the five mislocalized hSPCA1a variants from Fig. 10 in the triple pmr1Δ pmc1Δ cnb1Δ strain. Figure 12 shows that co-expression of wt hSPCA1a-BFP prevented the GFP tagged variants from accumulating in the vacuole and instead caused localization in the same Golgi compartment as wt hSPCA1a-BFP. To rule out that restoration of correct localization was due to oligomerization of wt- and HHD-hSPCA1a proteins and to clarify whether mislocalization was due to altered Ca2+ or Mn2+ homeostasis, we also co-expressed N-terminally BFP tagged human SERCA2b and the five mislocalized hSPCA1a variants. Data in Fig. 13 show that SERCA2b rescues localization of the mislocalized hSPCA1a proteins as it co-localizes with the four GFP tagged HHD-hSCPA1 variants and D350N, indicating that the four mislocalized HHD-hSPCA1a variants do indeed localize to the correct subcellular compartment when Ca2+ homeostasis is unperturbed, as SERCA2b cannot transport Mn2+.
Amino acid substitutions in hSPCA1 induce the unfolded protein response
As a tool to monitor whether in vivo folding of the fourteen clinically identified HHD hSPCA1a variants was compromised relative to that of the wt, we expressed the previously described GFP tagged versions of wt hSPCA1a, the fourteen HHD variants and the endogenous Pmr1 and Pmc1 proteins at 15 °C, 20 °C, 25 °C, 30 °C and 35 °C in the pmc1Δ pmr1Δ cnb1Δ yeast strain PAP4920 that carries an unfolded protein response reporter, UPR-lacZ in its chromosome. Expression was performed in presence of 20 mM CaCl2 and 0.24 µM MnSO459 to make yeast growth independent of the Ca2+-Mn2+ATPase activity of each expressed HHD-variant and to supply MnSO4 at a non-limiting and non-toxic concentration. Furthermore, inclusion of high concentration of Ca2+ to the growth medium reduces the chronically high UPR of pmr1Δ strains to wt-level61. Data in Fig. 14 show that expression of GFP tagged Pmr1, Pmc1, wt hSPCA1a or no hSPCA1a induced a very low and temperature independent unfolded protein response. It can be seen from Fig. 14 that apart from variant G309C all HHD variants evoked an unfolded protein response higher than wt, demonstrating that these HHD variants to various degrees are recognized by the protein folding quality control in the ER. Based on the level of induced UPR we divided the variants into low- and high-UPR inducers, respectively (Table 1). Members of the first category include variants G309C and T709M, along with the empty vector, Pmc1 and Pmr1 which all induced UPR to a level below that of the wt or up to 2 times that of wt. The remaining 12 variants all induced UPR to a level at least twice that of the wt. Most of the HHD variants investigated in the present study did not show a pronounced temperature-dependent effect on UPR induction.
To investigate the effect of having a healthy Ca2+-ATPase, and thus to more closely mimic the situation in HHD-keratinocytes, we co-expressed the investigated HHD-variants with either wt ATP2C1a or wt ATP2A2b in the presence of 20 mM CaCl2 in the growth medium. The results in Supplementary Figs S12 and S13 show that co-expression of a wt hSPCA1a or wt hSERCA2b, together with HHD-hSPCA1 prevents UPR induction. Lack of UPR in the presence of a wt Ca2+-ATPase indicates that Ca2+ dyshomeostasis may contribute significantly to UPR induction in yeast expressing HHD-ATP2C1a.
HHD is caused by ATP2C1 mutations that prevent accumulation of sufficient functional hSPCA1 in the secretory pathway. In addition to inactivation of ATPase activity an ATP2C1 missense mutation may compromise pre-mRNA splicing, mRNA stability, protein folding, protein stability or protein localization. The focus of the present paper was to analyze how 14 ATP2C1 missense mutations identified in HHD-patients affected Ca2+/Mn2+-ATPase activity using a yeast complementation assay. We furthermore analyzed how temperature influenced ATPase activity, protein accumulation, cellular localization and ER stress. The observed and diverse phenotypes of each mutation are summarized in Table 1.
Some of the mutants characterized in the present study have previously been investigated after expression in mammalian cells11,66. Table 2 shows a comparison between our results and previous results obtained from mammalian cells. Despite that different hosts were used for hSPCA1 production and different assays were applied for characterization, it can be seen that almost identical results were obtained in yeast and mammalian cells. Protein accumulation relative to wt is the same for all compared HHD variants and I580V shows wt activity in both expression systems while G309C affects Mn2+ interactions more than Ca2+. These data are in strong support for yeast being a relevant model system for studying certain aspects of HHD. Yeast however, lacks some of the proteins that interact with hSPCA1 in mammalian cells, e.g. the Orai1 Ca2+ channels66, and mutations affecting interaction with these proteins would not be picked up in a yeast based assay.
Lack of in vivo Ca2+/Mn2+ ATPase activity in HHD could potentially result from reduced hSPCA1 protein accumulation. Since all the investigated hSPCA1a variants, as well as the endogenous Pmr1 and Pmc1, were expressed from identical plasmids, we can assume that the rate of protein synthesis at a given temperature is the same for all the investigated proteins even though we cannot exclude that a missense mutation may affect e.g. mRNA stability. Therefore, differences in protein accumulation most probably originate from different rates of protein degradation and reflect protein stability. It is evident from Fig. 8 that at all temperatures seven of the investigated HHD-variants (C344Y, C411R, C490F, T570I, L584P, M641R and G789R) accumulated protein to a significantly lower membrane density than wt. The remaining seven variants (A304T, G309C, L318P, I580V, G645R, T709M and D742Y) accumulated protein to a level comparable to wt. However, none of these displayed a temperature dependent protein accumulation profile similar to that of the wt. Even though all hSPCA1 variants accumulated in a temperature independent way, the majority exposed a cold sensitive phenotype, showing that the accumulated protein is either non-functional or have very little ATPase activity at low temperatures. However, while HHD-mutants C344Y, C490F and L584P all accumulated protein to a lower density than wt, they were still able to complement the BAPTA-sensitive growth phenotype in liquid media almost as well as wt, indicating that the amount of functional hSPCA1a protein required for complementation is low. The other low accumulating variants all showed no or very little activity. Consequently, a reduced amount of accumulated hSPCA1a protein may not always be the cause of HHD.
Pmr1, the yeast orthologue of hSPCA1a, is located in the yeast Golgi and ER membrane17,31,32,33. We therefore anticipated that complementation requires that wt hSPCA1a and the investigated variants localize to these compartments. The bioimaging data in Fig. 9 show that wt hSPCA1a and all variants except G309C, I580V, G645R and D742Y, appear to localize similarly to Pmr1 in our pmc1Δ pmr1Δ cnb1Δ yeast strain. G309C, I580V, G645R and D742Y on the other hand all localized exclusively to the vacuolar membrane indicating that mis-targeting may be of importance for HHD. The fact these HHD variants exclusively accumulate in the vacuolar membrane and protein accumulation for these variants is on par with wt (Fig. 8), indicate that the proteins are not targeted to the vacuole for degradation. An interesting conclusion from these experiments is that the functional state does not dictate localization, as I580V in all assays showed wt-like complementation. Although the other mislocalization mutants all showed very little activity in our complementation assays, many other HHD variants localized correctly even though they possessed little or no complementation capacity (Table 1). The reason that I580V actually does complement the BAPTA and Mn2+ sensitive growth phenotypes, despite mislocalization, fits with the fact that over-expression of the vacuolar PMC1 can compensate for loss of PMR1 when grown in Ca2+-depleted media33, possibly because the protein is active en route to the vacuole, and perhaps in combination with an increased accumulation in ER and Golgi62,67. In this sense, the I580V variant may mimic the function of PMC1, but with the added functionality of Mn2+-transport.
Calcium homeostasis must play a role in localization as wt hSPCA1a and all mutants localized correctly in a wt yeast strain (Fig. 11) or in the calcium ATPase deficient yeast strain co-expressing either wt hSPCA1a (Fig. 12) or wt SERCA2b (Fig. 13). Since mislocalization is corrected by co-expression of SERCA2b, it must be the calcium homeostasis that is important as SERCA2b does not transport Mn2+.
The mislocalization we observed seems at first glance to contradict previous data11,66 showing wt localization of I580V and G309C in COS-1 cells and HEK293T cells, respectively. However, it should be kept in mind that these mammalian cells express endogenous wt SPCA1 as well as wt SERCA2. In our yeast model system, localization of I580V or G309C after co-expression of either wt hSPCA1a or hSERCA2b (Table 2) was identical to the localization observed in mammalian cells.
In the triple pmc1Δ pmr1Δ cnb1Δ yeast model system, homozygous expression of our panel of mutations seems to affect Mn2+ transport much more severely than Ca2+ transport (Table 1). As this was also observed in the single pmr1Δ strain, the difference is most likely attributable to the Ca2+ and Mn2+ transport capability of the HHD-hSPCA1 variants and not caused by hyper-accumulation of Ca2+ in the cytosol of the pmc1Δ pmr1Δ cnb1Δ strain. This suggests that a disturbed Mn2+ homeostasis may contribute significantly to HHD. In fact two of the mutations, L318P and C344Y, selectively affected Mn2+ transport without affecting Ca2+-transport. Another observation is that while most of the investigated mutations displayed a poor ability to complement the BAPTA sensitive growth deficiency of the host strain when expressed from a single copy of ATP2C1 cDNA, most of the mutations showed significant Ca2+-ATPase activity when expressed from approximately twenty copies of ATP2C1 cDNA (Figs 2 and 3). In contrast to this, Mn2+ toxicity could not be rescued by a twenty times increase in plasmid copy number suggesting that disturbed Mn2+ homeostasis may contribute significantly to HHD. Based on our results it may be interesting to measure the intracellular Mn2+ concentration in keratinocytes from HHD patients for comparison with that of healthy persons. The observed copy number effect on Ca2+-ATPase activity is in line with the general idea that haploinsufficiency is involved in HHD, while the copy number independent Mn2+ toxicity indicates a more complex genotype-phenotype relationship.
The results obtained after co-expression of each of the investigated HHD-alleles with wt ATP2C1a (hSPCA1a) (Supplementary Figs S4–S7) show that none of the investigated HHD-mutations exerted a dominant-negative effect on the Ca2+ or Mn2+ transport activity of wt hSPCA1a.
Five of the investigated amino acid substitutions are located in the transmembrane part of hSPCA1 and four of these (A304T, G309C, T709M and D742Y) are located in or close to the predicted ion-binding site created by amino acids in TM4, 5 and 6. G789R is located in TM7. None of the five mutations conferred Mn2+-tolerance irrespective of gene copy number, but all five conferred BAPTA sensitivity in a copy number dependent way. Each of the five mutations introduces a more bulky side chain and A304T, G309C and G789R additionally contributes a more polar side chain. The selective effect on Mn2+-ATPase activity may be due to altered geometry in the cation site that directly affects binding or release of Mn2+ more than of Ca2+, potentially due to the fact that the ionic radius of Mn2+ is considerably smaller than that of Ca2+ (0.8 Å vs. 0.99 Å respectively68) and therefore interactions with the binding site may affect Mn2+ more that Ca2+. It may seem counterintuitive that mutations preclude transport of the smaller Mn2+ ion, but not the larger Ca2+ ion. However, ion selectivity reflects the balance between the cost of ion dehydration and the benefits of interaction with the ion binding site69. As exemplified in K+ channels this results in a 10,000 times greater affinity for the larger K+ ion over the smaller Na+ ion. It has furthermore been shown that the selectivity of the K+ channel can be manipulated by adjusting the size of the ion-binding cavity69.
The reaction cycle of P-type ATPases involves large rearrangements and transmission of conformational changes initiated in the cytosolic A-, N- and P-domains and transduced to the membrane bound M-domain and vice-versa through long-range interactions between residues that are distantly remote in the primary structure70,71,72. Apart from amino acid substitutions in the ATP or Mg2+ binding sites, substitutions in one part of the protein may thus affect ATPase activity by reducing or preventing structural transmission from the cytoplasmic domains to the ion binding site in the membrane. It is well established that shortcutting the essential communication between A, N, P and M domains by limited proteolysis prevents ATPase activity73. Because at least some Ca2+-ATPase activity is preserved in several of the analyzed HHD variants, communication between the cytoplasmic part and the cation sites cannot be completely blocked; it is more likely that communication is impaired in such a way that the geometry of the cation binding site in the trans-membrane domain is altered and affects the smaller Mn2+ ion more than the larger Ca2+ -ion.
The simplest way to inactivate a protein is to interfere with its folding74 either by compromising the folding pathway or the stability of the finally folded structure. The circumstance that yeast can grow at a wide temperature range offers a unique opportunity to demonstrate for the first time, that nine out of the fourteen HHD mutations analyzed in the present study exposed a cold sensitive phenotype as complementation was absent at the lower temperatures (Fig. 7). Cold sensitive mutations are rare75 and usually result from trapping of a protein in a folding intermediate, that to various degrees prevents it from achieving the biologically active, three dimensional structure. Folding of the great majority of the HHD variants at low temperatures may thus be compromised by single amino acid substitutions. It is not obvious how cold sensitivity and the observation that wt hSPCA1a accumulates better at low temperature correlates with HHD. Even though the average skin temperature is 5–7 °C lower than the core temperature at normal ambient “comfort temperature”76,77 the disease exposes itself in intertriginous areas and parts of the skin exposed to friction where humidity and temperature are increased. HHD is almost exclusively pronounced in skin and extracutaneous symptoms have only been described in liver78. Given the importance of Ca2+ in a plethora of cellular processes it is surprising, that skin is the mainly affected organ in HHD. A putative explanation has been that other tissues must have compensatory Ca2+ transport mechanisms or that ATP2C1 expression is upregulated in keratinocytes as a consequence of the lower Ca2+ content of the upper layers in the epidermis37.
Despite their diverse phenotypes it is very interesting that homozygous expression of twelve out of the fourteen investigated HHD variants induced an unfolded protein response, because this may pave the way for a completely new way to target HHD. ER-stress has earlier been suggested to play an important role in the development of HHD due to the important role of Ca2+ in the secretory pathway of eukaryotic cells38. ER-stress and UPR can be induced by either depleting the ER of Ca2+ or by bona fide protein misfolding53,57,79,80,81. Consequently, HHD mutations may induce UPR in three ways: 1) By resulting in a non-functional or poorly functioning Ca2+-ATPase that is unable to counteract the constant Ca2+-leakage out of ER; 2) By resulting in an inactive, leaky protein that allows Ca2+ ions to more or less passively leak out of the ER; or 3) By misfolding.
Mutations resulting in poorly functioning or non-functioning hSPCA1a are expected to behave in a similar manner to the empty vector (Fig. 14) and the enzymatically dead D350N (Supplementary Fig. S14), and should thus induce a very low level of UPR in our yeast model system. To prevent the chronically induced UPR of pmr1Δ yeast in low Ca2+ media, we supplement the growth medium with 20 mM CaCl2 as this fully restores growth and UPR to wt levels60,61. The normal feedback inhibition of HACS is also absent in our yeast strain. Addition of 20 mM CaCl2 to the growth medium thus creates a large enough Ca2+ gradient from the outside, through the cytoplasm and across the ER membrane to allow a sufficient amount of Ca2+ to enter the ER lumen, to allow growth and suppress UPR. It has previously been shown that mutations in ATP2A2 can result in leaky SERCA2 proteins82. Under normal physiological conditions Ca2+ would leak out of the ER since the Ca2+ concentration in the ER is generally much greater than that of the cytosol. Under our growth conditions, the electrochemical gradient supports Ca2+ influx into the ER, and Ca2+ leakage out of the ER thus seems unlikely. Misfolding itself could theoretically trigger UPR by bona-fide misfolding (through the phylogenetically conserved Ire1 and BiP83,84,85) or by sequestering BiP and thereby increasing Ca2+ leakage through translocons80,86,87. As leakage out of ER is unlikely, UPR in our experiments most likely reflect misfolding of the expressed HHD-hSPCA1a variants.
Amino acids 723 to 729 (723-MNFPNPL-729, located in the TM5-TM6 loop (luminal loop 3), expose the most probable BiP binding site (Supplementary Fig. S15 and Fig. 1). It is therefore possible that structural perturbations in hSPCA1a due to amino acid substitutions may expose this BiP binding site and induce UPR. Supplementary Fig. S16 shows that TM5, along with TM7, is predicted to have the highest number of helix-helix contacts (7) of the 10 TM helices present in hSPCA1a. Thus mutations that affect membrane organization of TM helices 2, 3, 4, 7, 8, 9 or 10 could potentially interfere with TM5 and expose the BiP binding site. This may explain why HHD causing amino acid substitutions do not cluster in any particular parts of the hSPCA1 protein.
The UPR induced by homozygous expression of wt ATP2C1a is low and on par with that observed for the endogenous Pmc1 or Pmr1 expressed from the same vector, demonstrating that heterologous expression of the human wt ATP2C1a does not cause any significant increase in UPR (Fig. 14). High UPR is induced irrespective of the ability of the specific HHD variant to complement the growth phenotype of the yeast host cell (Table 1), showing that information on Ca2+/Mn2+ ATPase activity may not be sufficient to identify the cause of HHD. The fact that our data do not demonstrate any correlation between Ca2+ ATPase activity and induction of UPR further supports that it is most likely protein misfolding that is the cause of UPR induction. It may seem contradictory that some HHD hSPCA1a variants induce the unfolded protein response but at the same time show complementation. However, this may reflect the folding efficiency of each variant as we do not know how many functional hSPCA1 proteins are required for complementation.
The fact that most HHD-mutations do indeed induce UPR when expressed by themselves shows the relevance of our yeast model as a background-free model organism for HHD, since this effect would not be picked up in cells that harbor endogenous Ca2+-ATPases. While homozygous expression of HHD-hSPCA1a points to misfolding as the most probable cause for UPR induction, the results of the heterozygous co-expression of HHD-mutant ATP2C1a with either wt ATP2C1a or wt ATP2A2b seems to point towards Ca2+-dyshomeostasis in the ER as the cause for UPR. ER Ca2+ dyshomeostasis and protein folding are in fact highly interconnected, since ER chaperone function and thus protein folding, is indeed highly dependent on Ca2+ in the ER88. In tissues or part of tissues, where Ca2+ is naturally low, ER Ca2+ could become so low to cause the slightly more unstable HHD-SPCA1 to misfold and induce UPR. This could then initiate a negative spiral of less Ca2+ resulting in more unfolded proteins and so on. A consequence of UPR in mammalian cells is attenuation of translation and thus a reduction in the amount of protein entering the ER. This could reduce the number of active Ca2+-ATPases further acerbating the Ca2+ loss in the secretory pathway. Another consequence could be interference with production of proteins located in desmosomes, which often appear defective in HHD89.
The physiological role of both UPR and mislocalization in HHD keratinocytes remains to be investigated, but our data suggest that both could become a factor under low Ca2+ conditions in the ER.
An interesting phenotype displayed by several of the investigated mutations is sensitivity to Ca2+ as these mutants grew better in galactose medium containing a little BAPTA than in the same media containing 20 mM CaCl2 or 0 mM BAPTA. The latter medium is not supplemented with Ca2+ and thus only contains Ca2+ present as contamination in the agar and other media constituents. Ca2+ sensitivity has previously been described for yeast pmr1 mutants39,40,90 and pmc1 mutants40,60,91 but at much higher Ca2+ concentrations (200 mM) and both single mutants grow well at 100 mM CaCl240. pmc1Δ pmr1Δ cnb1Δ yeast have previously been shown to grow well at 20 mM CaCl260 and up to 200 mM CaCl292. The negative control (empty vector) did not display Ca2+ sensitivity in our experiments. Addition of 20 mM CaCl2 to the medium did not have an effect in the presence of glucose (i.e. when ATP2C1 is not expressed). Interestingly, only the replicative variants displayed Ca2+ sensitivity on media containing galactose and 20 mM CaCl2, indicating that it is the combination of high expression and the specific HHD variant that is responsible for this phenotype, as neither expression of wt nor the negative control conferred any Ca2+ sensitivity. We did not observe a clear correlation between Ca2+ sensitivity and other phenotypes investigated in our study and it is thus difficult to draw any conclusions on what may cause the observed Ca2+ sensitivity. However, keratinocytes defective in hSPCA1 display an inability to properly accumulate Ca2+ upon increases in extracellular Ca2+2,16, and a similar observation has also been made with yeast defective in Pmr129,90. Ca2+ sensitivity has even been suggested to be the most relevant phenotype for yeast pmr1 mutants in resembling keratinocyte pathology29.
In conclusion, results obtained in our yeast model system demonstrate that while the phenotypes exposed by our panel of HHD mutants are very diverse, UPR induction (12 out of 14) and Mn2+ sensitivity (12 out of 14) are the two most dominating phenotypes. This may indicate that HHD disease is a conformational disease and Mn2+ homeostasis may be more affected than Ca2+ homeostasis. A new approach towards treatment of HHD may thus focus on development of chemical chaperones to combat the hSPCA1 folding problems we have demonstrated.
The yeast strain K616 (ade2Δ1 can1-100 his3Δ 11.15 leu2Δ 3.112 trp1Δ 1 ura3Δ 1 pmc1::TRP1 pmr1::HIS3 cnb1::LEU2)60 was a kind gift from Kyle Cunningham, John Hopkins University, USA. Strain PAP4920 was generated by insertion of an unfolded protein response reporter, UPR-lacZ, into the ade2Δ1 locus of K616. Strain PAP9588 was constructed by inserting a nourseothricin resistance gene from plasmid pAG2586 into the TRP1 gene of PAP4920 by homologous recombination. The UPR-lacZ reporter is identical to that previously described58 except that the ADE2 marker substituted for the LYS2 marker. PAP1500 (α ura3–52 trp1:: GAL10-GAL4 lys2–801 leu2Δ1 his3Δ200 pep4::HIS3 prb1Δ1.6 R can1 GAL) has been described previously65. Yeast strain Y04534 (BY4741; MATa; ura3Δ0; leu2Δ0; his3Δ1; met15Δ0; YGL167c::kanMX4) was purchased from Euroscarf.
The replicative Gateway® compatible expression vector pPAP4997 was generated by insertion of a SacI-attR1- ccdB- CmR -attR2-HindIII fragment PCR amplified from pDEST15 (Invitrogen, USA) into similarly digested pEMBLyex493. The integrative Gateway® compatible expression vector pPAP5480 was constructed by relegation of MfeI digested pPAP4997. The replicative Gateway® compatible expression plasmids pPAP7177 and pPAP8754 were constructed by replacing the URA3 gene in pPA4997 with the ADE2 gene or the TRP1 gene, respectively.The integrative Gateway® compatible expression vector pPAP7010 was generated by inserting an ApaI-CYC-GAL-promoter- attR1-ccdB-CmR-attR2-BglII PCR fragment amplified from pPAP4997 into ApaI, BamHI digested pRS40294. Plasmids expressing either wt or amino acid substituted human hSPCA1a were generated by overlap extension PCR95 using an ATP2C1a cDNA clone obtained from Invitrogen, USA. Final PCR products were transferred by Gateway® Technology to pDONOR221 (Invitrogen, USA). After confirmation of the correct nucleotide sequence, all ATP2C1 alleles were transferred to pPAP4997 and pPAP5480 by LR-recombination. wt ATP2C1 was furthermore LR recombined into pPAP7010, pPAP7177 and pPAP8754. C-terminal in frame fusions to yEGFP96 was created by in vivo homologous recombination in yeast between SacI or HindIII digested ATP2C1 expression plasmids and yEGFP PCR fragments. C-terminal tagging of wt ATP2C1 with BFP was generated by in vivo homologous recombination in yeast between SalI, HindIII digested pPAP8754, a wt ATP2C1 PCR fragment and a codon optimized BFP (Gateway® TagBFP-AS-C, Evrogen, Russia) PCR fragment.
Complementation on agar plates
Yeast cells inoculated from −80 °C stock were grown at 30 °C in liquid synthetic minimal medium containing 2% glucose as sole carbon source and 20 mM CaCl2. Cultures maintained in the exponential growth phase were harvested, washed five times in sterile 18 mΩ water and subsequently re-suspended in 18 mΩ water to an OD450 = 0.5. 7 µl of this cell-suspension was spotted on minimal plates containing galactose as sole carbon source (SG plates) and either 20 mM CaCl2, BAPTA or MnSO4. Sterile filtered CaCl2 (from 1 M stock in dH2O), BAPTA (from 15 mM stock in 100 mM TES/KOH, pH = 6) or MnSO4 (from 100 mM stock in TES/KOH pH = 6) was added to the media to obtain the required concentrations. Plates were incubated at 15 °C, 20 °C, 25 °C, 30 °C or 35 °C, inspected daily and photographed.
Complementation in liquid media
Yeast cells were cultured from −80 °C stock as above. Complementation assays were performed in clear 96-well plates (well capacity: 400 µl). Each well contained 200 µl yeast culture. Medium was made from 100 µl 2x SG medium and 80 µl of CaCl2, BAPTA or MnSO4 (all dissolved in 100 mM TES/KOH, pH = 6) to the desired final concentrations. 20 µl of a cell suspension with OD450 = 0.5 in dH2O was added to each well. Plates were incubated at the desired temperature and OD450 of the cultures measured in a plate-reader (Multiskan RC, Thermo Labsystems) at appropriate time intervals. BAPTA (1, 2-bis(o-Aminophenoxy)ethane-N,N,N’,N’-tetraacetic Acid) was purchased as tetrasodium salt from Merck (cat.no.: 196418).
Growth of cells for quantitative fluorescence and UPR-lacZ measurements
Yeast cells were grown in SD medium supplemented with 20 mM CaCl2 and washed five times in 18 mΩ H2O. Each culture was used to inoculate shake flasks containing 50 ml of galactose minimal medium and either 20 mM CaCl2, 0 mM CaCl2 or 0.06 mM BAPTA to OD450 = 0.05. Shake flask were inoculated at 15 °C, 20 °C, 25 °C, 30 °C or 35 °C. Cultures were harvested when OD450 reached 1 to 1.5, washed in 18 mΩ H2O and immediately frozen at −80 °C. Crude yeast membranes and cytosolic fractions were isolated as previously described65.
Protein and enzymatic assays
Protein concentrations in cytosolic- and membrane preparations were determined by the BCA method97 according to the manufacturer’s specifications (Sigma-Aldrich, USA). β-galactosidase activities were determined in purified cytosolic preparations as described previously58.
Bioimaging of live yeast cells
C-terminally GFP/BFP tagged hSPCA1a proteins, N-terminally BFP tagged SERCA2b and FM4-64 stained cells98 were visualized at 1,000 x magnification with a Nikon Eclipse E600 fluorescence microscope equipped with an Optronics Magnafire model S99802 camera attached or a Leica SP5-X confocal microscope.
Quantification of ATP2C1a-GFP protein
The density of ATP2C1a-GFP protein in crude yeast membranes was quantified using a standard curve made from purified GFP protein as described previously99.
Prediction of BIP binding sites in ER resident parts of ATP2C1was performed according to Blond-Elguindi et al.100. ER resident parts were identified by the TMHMM software101 while potential interactions between transmembrane helixes were predicted by the TMHIT program102.
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Sudbrak, R. et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum. Mol. Genet. 9, 1131–1140 (2000).
Hu, Z. et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat. Genet. 24, 61–65 (2000).
Ficociello, G. et al. Glutathione S-transferase -subunit as a phenotypic suppressor of pmr1Delta strain, the Kluyveromyces lactis model for Hailey-Hailey disease. Biochim. Biophys. Acta 1863, 2650–2657 (2016).
Biolcati, G. et al. Efficacy of the melanocortin analogue Nle4-D-Phe7-alpha-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease. Clin. Exp. Dermatol. 39, 168–175 (2014).
Cialfi, S. et al. The loss of ATP2C1 impairs the DNA damage response and induces altered skin homeostasis: Consequences for epidermal biology in Hailey-Hailey disease. Sci. Rep. 6, 31567 (2016).
Kellermayer, R., Aiello, D. P., Miseta, A. & Bedwell, D. M. Extracellular Ca(2+) sensing contributes to excess Ca(2+) accumulation and vacuolar fragmentation in a pmr1Delta mutant of S. cerevisiae. J. Cell Sci. 116, 1637–1646 (2003).
Micaroni, M., Giacchetti, G., Plebani, R., Xiao, G. G. & Federici, L. ATP2C1 gene mutations in Hailey-Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking. Cell Death. Dis. 7, e2259 (2016).
Deng, H. & Xiao, H. The role of the ATP2C1 gene in Hailey-Hailey disease. Cell Mol. Life Sci. 74, 3687–3696 (2017).
Nellen,R.G. et al. Mendelian Disorders of Cornification Caused by Defects in Intracellular Calcium Pumps: Mutation Update and Database for Variants in ATP2A2 and ATP2C1 Associated with Darier Disease and Hailey-Hailey Disease. Hum. Mutat.(2016).
Bublitz, M., Morth, J. P. & Nissen, P. P-type ATPases at a glance. J. Cell Sci. 124, 2515–2519 (2011).
Fairclough, R. J. et al. Effect of Hailey-Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1). J. Biol. Chem. 278, 24721–24730 (2003).
Dode, L. et al. Functional comparison between secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and sarcoplasmic reticulum Ca2+-ATPase (SERCA) 1 isoforms by steady-state and transient kinetic analyses. J. Biol. Chem. 280, 39124–39134 (2005).
Portillo, F., de Larrinoa, I. F. & Serrano, R. Deletion analysis of yeast plasma membrane H+-ATPase and identification of a regulatory domain at the carboxyl-terminus. FEBS Lett. 247, 381–385 (1989).
Rudashevskaya, E. L., Ye, J., Jensen, O. N., Fuglsang, A. T. & Palmgren, M. G. Phosphosite mapping of P-type plasma membrane H+-ATPase in homologous and heterologous environments. J. Biol. Chem. 287, 4904–4913 (2012).
Brini, M., Carafoli, E. & Cali, T. The plasma membrane calcium pumps: focus on the role in (neuro)pathology. Biochem. Biophys. Res. Commun. 483, 1116–1124 (2017).
Behne, M. J. et al. Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J. Invest Dermatol. 121, 688–694 (2003).
Ton, V. K., Mandal, D., Vahadji, C. & Rao, R. Functional expression in yeast of the human secretory pathway Ca(2+), Mn(2+)-ATPase defective in Hailey-Hailey disease. J. Biol. Chem. 277, 6422–6427 (2002).
Vanoevelen, J. et al. The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions. J. Biol. Chem. 280, 22800–22808 (2005).
Wootton, L. L., Argent, C. C., Wheatley, M. & Michelangeli, F. The expression, activity and localisation of the secretory pathway Ca2+ -ATPase (SPCA1) in different mammalian tissues. Biochim. Biophys. Acta 1664, 189–197 (2004).
Matsuda, M. et al. Mutation-dependent effects on mRNA and protein expressions in cultured keratinocytes of Hailey-Hailey disease. Exp. Dermatol. 23, 514–516 (2014).
Shibata, A., Sugiura, K., Kimura, U., Takamori, K. & Akiyama, M. A novel ATP2C1 early truncation mutation suggests haploinsufficiency as a pathogenic mechanism in a patient with Hailey-Hailey disease. Acta Derm. Venereol. 93, 719–720 (2013).
Okunade, G. W. et al. Loss of the Atp2c1 secretory pathway Ca(2+)-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J. Biol. Chem. 282, 26517–26527 (2007).
Elias, P., Ahn, S., Brown, B., Crumrine, D. & Feingold, K. R. Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J. Invest Dermatol. 119, 1269–1274 (2002).
Mao-Qiang, M. et al. Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice. Exp. Dermatol. 6, 36–40 (1997).
Mauro, T. et al. Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. J. Invest Dermatol. 111, 1198–1201 (1998).
Pillai, S., Bikle, D. D., Hincenbergs, M. & Elias, P. M. Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J. Cell Physiol 134, 229–237 (1988).
Pillai, S., Bikle, D. D., Mancianti, M. L., Cline, P. & Hincenbergs, M. Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J. Cell Physiol 143, 294–302 (1990).
Kitajima, Y. Mechanisms of desmosome assembly and disassembly. Clin. Exp. Dermatol. 27, 684–690 (2002).
Kellermayer, R. Hailey-Hailey disease as an orthodisease of PMR1 deficiency in Saccharomyces cerevisiae. FEBS Lett. 579, 2021–2025 (2005).
Rudolph, H. K. et al. The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family. Cell 58, 133–145 (1989).
Antebi, A. & Fink, G. R. The yeast Ca(2+)-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution. Mol. Biol. Cell 3, 633–654 (1992).
Sorin, A., Rosas, G. & Rao, R. PMR1, a Ca2+-ATPase in yeast Golgi, has properties distinct from sarco/endoplasmic reticulum and plasma membrane calcium pumps. J. Biol. Chem. 272, 9895–9901 (1997).
Dürr, G. et al. The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol. Biol. Cell 9, 1149–1162 (1998).
Strayle, J., Pozzan, T. & Rudolph, H. K. Steady-state free Ca(2+) in the yeast endoplasmic reticulum reaches only 10 microM and is mainly controlled by the secretory pathway pump pmr1. EMBO J. 18, 4733–4743 (1999).
Kaufman, R. J., Swaroop, M. & Murtha-Riel, P. Depletion of manganese within the secretory pathway inhibits O-linked glycosylation in mammalian cells. Biochemistry 33, 9813–9819 (1994).
Dode, L., Vanoevelen, J., Missiaen, L., Raeymaekers, L. & Wuytack, F. Ca2+/Mn2+ pumps of the Golgi apparatus and Hailey-Hailey disease in New Comprehensive Biochemistry: Calcium A Matter of Life or Death (eds Joachim Krebs and Marek Michalak) 229–265 (Elsevier, 2007).
Ramos-Castaneda, J. et al. Deficiency of ATP2C1, a Golgi ion pump, induces secretory pathway defects in endoplasmic reticulum (ER)-associated degradation and sensitivity to ER stress. J. Biol. Chem. 280, 9467–9473 (2005).
Shull, G. E., Miller, M. L. & Prasad, V. Secretory pathway stress responses as possible mechanisms of disease involving Golgi Ca2+ pump dysfunction. Biofactors 37, 150–158 (2011).
Halachmi, D. & Eilam, Y. Elevated cytosolic free Ca2+ concentrations and massive Ca2+ accumulation within vacuoles, in yeast mutant lacking PMR1, a homolog of Ca2+ -ATPase. FEBS Lett. 392, 194–200 (1996).
Miseta, A., Fu, L., Kellermayer, R., Buckley, J. & Bedwell, D. M. The Golgi apparatus plays a significant role in the maintenance of Ca2+ homeostasis in the vps33Delta vacuolar biogenesis mutant of Saccharomyces cerevisiae. J. Biol. Chem. 274, 5939–5947 (1999).
Lapinskas, P. J., Cunningham, K. W., Liu, X. F., Fink, G. R. & Culotta, V. C. Mutations in PMR1 suppress oxidative damage in yeast cells lacking superoxide dismutase. Mol. Cell Biol. 15, 1382–1388 (1995).
Park, S. Y., Seo, S. B., Lee, S. J., Na, J. G. & Kim, Y. J. Mutation in PMR1, a Ca(2+)-ATPase in Golgi, confers salt tolerance in Saccharomyces cerevisiae by inducing expression of PMR2, an Na(+)-ATPase in plasma membrane. J. Biol. Chem. 276, 28694–28699 (2001).
Missiaen, L. et al. SPCA1 pumps and Hailey-Hailey disease. Biochem. Biophys. Res. Commun. 322, 1204–1213 (2004).
Mukhopadhyay, S. & Linstedt, A. D. Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn2+ efflux and protects against toxicity. Proc. Natl. Acad. Sci. USA 108, 858–863 (2011).
Van Baelen, K. et al. The Ca2+/Mn2+ pumps in the Golgi apparatus. Biochim. Biophys. Acta 1742, 103–112 (2004).
Milatovic, D., Zaja-Milatovic, S., Gupta, R. C., Yu, Y. & Aschner, M. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol. Appl. Pharmacol. 240, 219–225 (2009).
Roth, J. A., Horbinski, C., Higgins, D., Lein, P. & Garrick, M. D. Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation. Neurotoxicology 23, 147–157 (2002).
Zhao, P. et al. Manganese chloride-induced G0/G1 and S phase arrest in A549 cells. Toxicology 250, 39–46 (2008).
Hwang, L. Y., Lee, J. B., Richard, G., Uitto, J. J. & Hsu, S. Type 1 segmental manifestation of Hailey-Hailey disease. J. Am. Acad. Dermatol. 49, 712–714 (2003).
Poblete-Gutierrez, P. et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J. Clin. Invest 114, 1467–1474 (2004).
Periasamy, M. et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 274, 2556–2562 (1999).
Cox, J. S. & Walter, P. A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response. Cell 87, 391–404 (1996).
Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081–1086 (2011).
Bernales, S., Papa, F. R. & Walter, P. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol. 22, 487–508 (2006).
Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529 (2007).
Hetz, C., Martinon, F., Rodriguez, D. & Glimcher, L. H. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol Rev. 91, 1219–1243 (2011).
Hetz, C. & Papa, F. R. The Unfolded Protein Response and Cell Fate Control. Mol. Cell (2017).
Jorgensen, J. R. & Pedersen, P. A. Role of phylogenetically conserved amino acids in folding of Na,K-ATPase. Biochemistry 40, 7301–7308 (2001).
Wickersham, L. J. Taxonomy of yeasts. United States Department of Agriculture Technical Bulletin (1951).
Cunningham, K. W. & Fink, G. R. Calcineurin-dependent growth control in Saccharomyces cerevisiae mutants lacking PMC1, a homolog of plasma membrane Ca2+ ATPases. J. Cell Biol. 124, 351–363 (1994).
Bonilla, M., Nastase, K. K. & Cunningham, K. W. Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J. 21, 2343–2353 (2002).
Locke, E. G., Bonilla, M., Liang, L., Takita, Y. & Cunningham, K. W. A homolog of voltage-gated Ca(2+) channels stimulated by depletion of secretory Ca(2+) in yeast. Mol. Cell Biol. 20, 6686–6694 (2000).
Bonilla, M. & Cunningham, K. W. Mitogen-activated protein kinase stimulation of Ca(2+) signaling is required for survival of endoplasmic reticulum stress in yeast. Mol. Biol. Cell 14, 4296–4305 (2003).
Ton, V. K. & Rao, R. Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases. Am. J. Physiol Cell Physiol 287, C580–C589 (2004).
Pedersen, P. A., Rasmussen, J. H. & Joorgensen, P. L. Expression in high yield of pig alpha 1 beta 1 Na,K-ATPase and inactive mutants D369N and D807N in Saccharomyces cerevisiae. J. Biol. Chem. 271, 2514–2522 (1996).
Smaardijk, S. et al. Store-independent coupling between the Secretory Pathway Ca(2+) transport ATPase SPCA1 and Orai1 in Golgi stress and Hailey-Hailey disease. Biochim. Biophys. Acta 1865, 855–862 (2018).
Marchi, V., Sorin, A., Wei, Y. & Rao, R. Induction of vacuolar Ca2+-ATPase and H+/Ca2+ exchange activity in yeast mutants lacking Pmr1, the Golgi Ca2+-ATPase. FEBS Lett. 454, 181–186 (1999).
Moody, B. Comprative Inorganic Chemistry (Edward Arnold, London, 1978).
Gouaux, E. & MacKinnon, R. Principles of selective ion transport in channels and pumps. Science 310, 1461–1465 (2005).
Toyoshima, C., Nakasako, M., Nomura, H. & Ogawa, H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405, 647–655 (2000).
Jorgensen, P. L. & Andersen, J. P. Structural basis for E1-E2 conformational transitions in Na,K-pump and Ca-pump proteins. J. Membr. Biol. 103, 95–120 (1988).
Jorgensen, P. L., Hakansson, K. O. & Karlish, S. J. Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu. Rev. Physiol 65, 817–849 (2003).
Jorgensen, P. L. & Petersen, J. Chymotryptic cleavage of alpha-subunit in E1-forms of renal (Na+ + K+)-ATPase: effects on enzymatic properties, ligand binding and cation exchange. Biochim. Biophys. Acta 821, 319–333 (1985).
Pace, C. N. Conformational stability of globular proteins. Trends Biochem. Sci. 15, 14–17 (1990).
King, J., Haase, C., & Yu, M. Temperature-Sensitive Mutations Affecting Kinetic Steps in Protein-Folding Pathways in Protein Engineering (eds Oxender, D. L. & Fox, F. C.) 109–121 (Alan R. Liss, New York, 1987).
Olesen, B. W. & Fanger, P. O. The skin temperature distribution for resting man in comfort. Arch. Sci. Physiol (Paris) 27, 385–393 (1973).
Webb, P. Temperatures of skin, subcutaneous tissue, muscle and core in resting men in cold, comfortable and hot conditions. Eur. J. Appl. Physiol Occup. Physiol 64, 471–476 (1992).
Amagai, M. et al. A case of generalized Hailey-Hailey disease with fatal liver injury. Keio J. Med. 50, 109–116 (2001).
Schonthal, A. H. Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica. (Cairo.) 2012, 857516 (2012).
Paredes, R. M., Bollo, M., Holstein, D. & Lechleiter, J. D. Luminal Ca2+ depletion during the unfolded protein response in Xenopus oocytes: cause and consequence. Cell Calcium 53, 286–296 (2013).
Krebs, J., Agellon, L. B. & Michalak, M. Ca(2+) homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling. Biochem. Biophys. Res. Commun. 460, 114–121 (2015).
Kaneko, M., Desai, B. S. & Cook, B. Ionic leakage underlies a gain-of-function effect of dominant disease mutations affecting diverse P-type ATPases. Nat. Genet. 46, 144–151 (2014).
Kimata, Y. et al. Two regulatory steps of ER-stress sensor Ire1 involving its cluster formation and interaction with unfolded proteins. J. Cell Biol. 179, 75–86 (2007).
Korennykh, A. V. et al. The unfolded protein response signals through high-order assembly of Ire1. Nature 457, 687–693 (2009).
Li, H., Korennykh, A. V., Behrman, S. L. & Walter, P. Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering. Proc. Natl. Acad. Sci. USA 107, 16113–16118 (2010).
Schauble, N. et al. BiP-mediated closing of the Sec. 61 channel limits Ca2+ leakage from the ER. EMBO J. 31, 3282–3296 (2012).
Schorr, S. et al. Co-chaperone Specificity in Gating of the Polypeptide Conducting Channel in the Membrane of the Human Endoplasmic Reticulum. J. Biol. Chem. 290, 18621–18635 (2015).
Ellgaard, L., McCaul, N., Chatsisvili, A. & Braakman, I. Co- and Post-Translational Protein Folding in the ER. Traffic. 17, 615–638 (2016).
Dhitavat, J., Fairclough, R. J., Hovnanian, A. & Burge, S. M. Calcium pumps and keratinocytes: lessons from Darier’s disease and Hailey-Hailey disease. Br. J. Dermatol. 150, 821–828 (2004).
Szigeti, R., Miseta, A. & Kellermayer, R. Calcium and magnesium competitively influence the growth of a PMR1 deficient Saccharomyces cerevisiae strain. FEMS Microbiol. Lett. 251, 333–339 (2005).
Miseta, A., Kellermayer, R., Aiello, D. P., Fu, L. & Bedwell, D. M. The vacuolar Ca2+/H+ exchanger Vcx1p/Hum1p tightly controls cytosolic Ca2+ levels in S. cerevisiae. FEBS Lett. 451, 132–136 (1999).
Degand, I. et al. Rabbit sarcoplasmic reticulum Ca(2+)-ATPase replaces yeast PMC1 and PMR1 Ca(2+)-ATPases for cell viability and calcineurin-dependent regulation of calcium tolerance. Mol. Microbiol. 31, 545–556 (1999).
Cesareni, G. & Murray, J. A. H. Plasmid vectors carrying the replicatiuon origin of filamentous single-stranded phages in Genetic Engineering: Principles and Methods (ed. Setlow, J. K.) 135–154 (Plenum Press, New York, 1987).
Brachmann, C. B. et al. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14, 115–132 (1998).
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51–59 (1989).
Cormack, B. P. et al. Yeast-enhanced green fluorescent protein (yEGFP)a reporter of gene expression in Candida albicans. Microbiology 143(Pt 2), 303–311 (1997).
Smith, P. K. et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76–85 (1985).
Vida, T. A. & Emr, S. D. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol. 128, 779–792 (1995).
Bomholt, J., Helix-Nielsen, C., Scharff-Poulsen, P. & Pedersen, P. A. Recombinant production of human Aquaporin-1 to an exceptional high membrane density in Saccharomyces cerevisiae. PLoS. One. 8, e56431 (2013).
Blond-Elguindi, S. et al. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75, 717–728 (1993).
Krogh, A., Larsson, B., von, H. G. & Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567–580 (2001).
Lo, A. et al. Predicting helix-helix interactions from residue contacts in membrane proteins. Bioinformatics. 25, 996–1003 (2009).
Axelsen, K. B. & Palmgren, M. G. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 46, 84–101 (1998).
The authors wish to thank David Sorensen for excellent technical assistance. The present work has been supported by the Lundbeck Foundation and the NovoNordisk Foundation. Confocal microscopy data were collected at the Advanced Bioimaging Centre, University of Copenhagen.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Muncanovic, D., Justesen, M.H., Preisler, S.S. et al. Characterization of Hailey-Hailey Disease-mutants in presence and absence of wild type SPCA1 using Saccharomyces cerevisiae as model organism. Sci Rep 9, 12442 (2019) doi:10.1038/s41598-019-48866-y